Status:
UNKNOWN
Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples
Lead Sponsor:
Medical University of Vienna
Conditions:
Prediabetic State
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the present study is to investigate epigenetics based modifications and biomarkers in the saliva and blood in diabetic patients.
Eligibility Criteria
Inclusion
- type 2 diabetic patients
- prediabetic patients
- women with gestational diabetes
- healthy control subjects without diabetes
- healthy pregnant women
Exclusion
- cancer disease
- infectious diseases such as hepatitis or HIV
- malignoms
- patients with claustrophoby
Key Trial Info
Start Date :
February 29 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT04011228
Start Date
February 29 2016
End Date
January 1 2020
Last Update
September 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090